ImmunoMet Therapeutics, Inc. Employee Directory

Q: What is ImmunoMet Therapeutics, Inc. known for?

ImmunoMet Therapeutics, Inc. was founded in 2015. ImmunoMet Therapeutics, Inc. operates in the Biotechnology Research industry.

Q: How many employees does ImmunoMet Therapeutics, Inc. have currently?

ImmunoMet Therapeutics, Inc. has approximately 7 employees.

Biotechnology ResearchUnited States2-10 Employees

ImmunoMet Therapeutics is a clinical stage biotech targeting cellular metabolism to develop novel anti-fibrotic and anti-tumor therapies. Our lead molecule, IM156, is a protein complex 1 (PC1) inhibitor that targets the Oxidative Phosphorylation (OXPHOS) pathway in mitochondria and decreases aberrant cell growth in fibrosis and select cancer cells. IM156 is the first potent PC1 inhibitor to complete Phase 1 with a good tolerability. In fibrosis, ImmunoMet is currently conducting a Phase 1 study in healthy volunteers and plan to progress into Phase 2 PoC study in IPF patients in 4Q2021. The company was founded in 2015, is a spin-off from HanAll Biopharma, a Korean midsized public company, and has raised $31 MM post-spin-off.

Find ImmunoMet Therapeutics, Inc. employees' phone numbers or email addresses

ImmunoMet Therapeutics, Inc. Global Highlights

North America
8

United States Of America
8

ImmunoMet Therapeutics, Inc.'s Leadership

W.
Chief Executive Officer
Mobile Phone
Email
S. K.
Chief Executive Officer (chief Executive Officer)
Mobile Phone
Email
S. P.
Vp Cmc & Operations
Mobile Phone
Email
M. B.
Consulting Chief Financial Officer
Mobile Phone
Email
T. C.
Co-Chief Executive Officer
Mobile Phone
Email
B. C.
Board Director
Mobile Phone
Email
S. S. K.
Bod
Mobile Phone
Email

Contact profiles from ImmunoMet Therapeutics, Inc.

Name

Title

Contact Info

Location

Last Update

W.
Chief Executive Officer
Mobile Phone
Email
United StatesMichigan
Sep 09, 2025
M. B.
Consulting Chief Financial Officer
Mobile Phone
Email
United StatesNew York
Oct 23, 2025
T. C.
Co-Chief Executive Officer
Mobile Phone
Email
United StatesMichigan
Aug 11, 2025
S. K.
Chief Executive Officer (chief Executive Officer)
Mobile Phone
Email
Oct 23, 2024
S. P.
Vp Cmc & Operations
Mobile Phone
Email
United StatesTexas
Nov 11, 2025
B. C.
Board Director
Mobile Phone
Email
Nov 11, 2025
S. S. K.
Bod
Mobile Phone
Email
Aug 10, 2025

Frequently Asked Questions

What is ImmunoMet Therapeutics, Inc. known for?

ImmunoMet Therapeutics, Inc. was founded in 2015 operates in the Biotechnology Research industry. The company's main headquarters is located in 2450 HOLCOMBE BLVD, Houston, Texas 77021, US. Explore ImmunoMet Therapeutics, Inc.'s company overview page for more information.

What is ImmunoMet Therapeutics, Inc.'s most common email format?

ImmunoMet Therapeutics, Inc. employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more ImmunoMet Therapeutics, Inc. email formats with LeadIQ.

How many employees does ImmunoMet Therapeutics, Inc. have currently?

ImmunoMet Therapeutics, Inc. has approximately 7 employees as of October 2025. These team members are located across 1 continents, including North America.

Who are ImmunoMet Therapeutics, Inc.'s key employees and leadership?

As of October 2025, ImmunoMet Therapeutics, Inc.'s key employees include:

Chief Executive Officer: W.
Chief Executive Officer (chief Executive Officer): S. K.
Vp Cmc & Operations: S. P.
Consulting Chief Financial Officer: M. B.
Co-Chief Executive Officer: T. C.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking